Susan E Merel1, Cynthia A Meier2, Christy M McKinney1,3, Paul S Pottinger4. 1. 1 Division of General Internal Medicine, Department of Medicine, University of Washington , Seattle, Washington. 2. 2 Providence Hospice of Seattle , Seattle, Washington. 3. 3 Department of Oral Health Sciences, University of Washington , Seattle, Washington. 4. 4 Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington , Seattle, Washington.
Abstract
BACKGROUND: Antimicrobials are commonly used in patients near the end of life, but the percentage and predictors of patients prescribed antibiotics while hospitalized on a comfort care protocol are unknown. OBJECTIVE: To determine how often patients in the acute care setting are continued on antimicrobials when they are transitioned to comfort-focused care and to describe patient characteristics correlated with antimicrobial use. DESIGN: Retrospective cohort study conducted from June 2012 to August 2014. SETTING: Two interrelated academic medical centers. PATIENTS: Inpatients >18 years old transitioned to a comfort care protocol. MEASUREMENTS: Administration of antimicrobials to patients on the comfort care protocol. ANALYSIS: We generated descriptive statistics and used a modified Poisson regression to estimate unadjusted and adjusted associations along with 95% confidence intervals (CIs) and p-values. RESULTS: There were 1881 patients included in the study; 77% of patients ultimately transitioned to a comfort care protocol received antimicrobials during their admission and 82% died in hospital. Of the 711 alive at ≥24 hours after comfort care orders, 111 (15.6%) were still on antimicrobials. After adjusting for age, a documented infection was positively associated with being on antibiotics (adjusted relative risk [ARR] = 1.46, 95% CI: 1.00-2.12, p = 0.05). Patients in the medical and surgical intensive care units (ICUs) were less likely than those on medicine to receive antimicrobials (MICU ARR = 0.32, 95% CI: 0.14-0.72, p = 0.01; SICU/Neuro ARR = 0.32, 95% CI: 0.12-0.85, p = 0.02). CONCLUSIONS: Antimicrobial use is relatively high in hospitalized patients near the end of life, even when the goal is comfort.
BACKGROUND: Antimicrobials are commonly used in patients near the end of life, but the percentage and predictors of patients prescribed antibiotics while hospitalized on a comfort care protocol are unknown. OBJECTIVE: To determine how often patients in the acute care setting are continued on antimicrobials when they are transitioned to comfort-focused care and to describe patient characteristics correlated with antimicrobial use. DESIGN: Retrospective cohort study conducted from June 2012 to August 2014. SETTING: Two interrelated academic medical centers. PATIENTS: Inpatients >18 years old transitioned to a comfort care protocol. MEASUREMENTS: Administration of antimicrobials to patients on the comfort care protocol. ANALYSIS: We generated descriptive statistics and used a modified Poisson regression to estimate unadjusted and adjusted associations along with 95% confidence intervals (CIs) and p-values. RESULTS: There were 1881 patients included in the study; 77% of patients ultimately transitioned to a comfort care protocol received antimicrobials during their admission and 82% died in hospital. Of the 711 alive at ≥24 hours after comfort care orders, 111 (15.6%) were still on antimicrobials. After adjusting for age, a documented infection was positively associated with being on antibiotics (adjusted relative risk [ARR] = 1.46, 95% CI: 1.00-2.12, p = 0.05). Patients in the medical and surgical intensive care units (ICUs) were less likely than those on medicine to receive antimicrobials (MICU ARR = 0.32, 95% CI: 0.14-0.72, p = 0.01; SICU/Neuro ARR = 0.32, 95% CI: 0.12-0.85, p = 0.02). CONCLUSIONS: Antimicrobial use is relatively high in hospitalized patients near the end of life, even when the goal is comfort.
Authors: Erin Diviney Chun; Phillip E Rodgers; Caroline A Vitale; Curtis D Collins; Preeti N Malani Journal: Am J Hosp Palliat Care Date: 2009-12-03 Impact factor: 2.500
Authors: Joseph H Rosenberg; Jennifer S Albrecht; Erik K Fromme; Brie N Noble; Jessina C McGregor; Angela C Comer; Jon P Furuno Journal: J Palliat Med Date: 2013-10-23 Impact factor: 2.947
Authors: Jennifer S Albrecht; Jessina C McGregor; Erik K Fromme; David T Bearden; Jon P Furuno Journal: J Pain Symptom Manage Date: 2013-01-11 Impact factor: 3.612
Authors: Jon P Furuno; Brie N Noble; Kristi N Horne; Jessina C McGregor; Miriam R Elman; David T Bearden; Eric W Walsh; Erik K Fromme Journal: Antimicrob Agents Chemother Date: 2014-07-07 Impact factor: 5.191
Authors: Olivia S Kates; Elizabeth M Krantz; Juhye Lee; John Klaassen; Jessica Morris; Irina Mezheritsky; Ania Sweet; Frank Tverdek; Elizabeth T Loggers; Steven A Pergam; Catherine Liu Journal: Open Forum Infect Dis Date: 2021-08-02 Impact factor: 4.423